It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
INTERNATIONAL medical cannabis platform company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has signed a multi-year supply agreement with European medical cannabis leader Cansativa GmbH (“Cansativa Group” or “Cansativa”) to supply EU-GMP quality THC dried flower strains cultivated from its Portuguese operations at Holigen.
Cansativa won the sole contract to distribute homegrown medical cannabis to the domestic market but will the move towards adult-use in Germany impact its business?
WITH negotiations underway on the formation of a new German government supporters of a regulated adult-use cannabis market believe a significant moment in European history beckons.
HOMEGROWN medical cannabis is now available to German patients for the first time.
